| 2013-10 | Is Isoniazid Treatment For LTBI Safe For RA Patients With TNF Inhibitor Therapy? | 유대현 |
| 2018-09 | Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy | 유대현 |
| 2012-06 | Korean Observational Study Network for Arthritis (KORONA): Establishment of a Prospective Multicenter Cohort for Rheumatoid Arthritis in South Korea | 유대현 |
| 2019-02 | Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial | 유대현 |
| 2015-04 | Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients | 유대현 |
| 2016-04 | Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data | 유대현 |
| 2013-06 | MEFV gene mutations and their clinical significance in Korean patients with adult-onset Still's disease | 유대현 |
| 2011-10 | Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-kappa B and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis | 유대현 |
| 2013-06 | METHOTREXATE DOSE AND OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS | 유대현 |
| 2013-05 | Mortality factors in idiopathic inflammatory myopathy: focusing on malignancy and interstitial lung disease | 유대현 |
| 2017-03 | A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis | 유대현 |
| 2012-09 | Natural Killer T Cell Deficiency in Active Adult-Onset Still's Disease Correlation of Deficiency of Natural Killer T Cells With Dysfunction of Natural Killer Cells | 유대현 |
| 2011-06 | Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity | 유대현 |
| 2018-05 | Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil | 유대현 |
| 2020-11 | A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis | 유대현 |
| 2013-06 | A PHASE 3 RANDOMISED CONTROLLED TRIAL TO COMPARE CT-P13 WITH INFLIXIMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 54 WEEK RESULTS FROM THE PLANETRA STUDY | 유대현 |
| 2016-04 | A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study | 유대현 |
| 2013-06 | PILOT TRIAL OF TOCILIZUMAB FOR REFRACTORY PATIENTS WITH ADULT ONSET STILL'S DISEASE | 유대현 |
| 2013-06 | PREDICTOR OF RENAL SURVIVAL IN LUPUS NEPHRITIS IN KOREA | 유대현 |
| 2016-09 | Prevalence and possible causes of hypouricemia at a tertiary care hospital | 유대현 |
| 2019-04 | Prevalence and predictors for sustained remission in rheumatoid arthritis | 유대현 |
| 2013-06 | PREVALENCE AND PREDICTORS FOR SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS | 유대현 |
| 2013-06 | PREVALENCE AND PREDICTORS FOR SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS | 유대현 |
| 2018-07 | Prevalence of co-morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross-sectional study (COMORA) | 유대현 |
| 2013-10 | Quality Of Life In Rheumatoid Arthritis: Cross-National Comparison Study Between US and South Korea | 유대현 |
| 2013-10 | A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study | 유대현 |
| 2013-10 | A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study | 유대현 |
| 2013-06 | A RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 1 STUDY COMPARING THE PHARMACOKINETICS, SAFETY AND EFFICACY OF CT-P13 AND INFLIXIMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 54 WEEK RESULTS FROM THE PLANETAS STUDY | 유대현 |
| 2013-07 | The relationship between peripheral arthritis and anti-cyclic citrullinated peptide antibodies in ankylosing spondylitis | 유대현 |
| 2015-11 | Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-alpha treatment and comparison to other guidelines | 유대현 |
